Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Agios Pharmaceuticals stock have an average target of 56.57, with a low estimate of 46 and a high estimate of 75. The average target predicts an increase of 104.52% from the current stock price of 27.66.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$46	$56.57	$56	$75
Change	+66.31%	+104.52%	+102.46%	+171.15%

* Price targets were last updated on Feb 24, 2025.

Analyst Ratings

The average analyst rating for Agios Pharmaceuticals stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	0	0	1	1	1
Buy	4	4	4	4	4	4
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $58	Strong Buy	Reiterates	$58	+109.69%	Feb 24, 2025
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Dec 18, 2024
Gregory Renza RBC Capital	RBC Capital	Buy Maintains $55 → $57	Buy	Maintains	$55 → $57	+106.07%	Dec 10, 2024
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $53 → $75	Buy	Maintains	$53 → $75	+171.15%	Dec 9, 2024
Gregory Renza RBC Capital	RBC Capital	Buy Reiterates $55	Buy	Reiterates	$55	+98.84%	Nov 1, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

51.51M

Increased by 41.13%

from 36.50M

Revenue Next Year

172.54M

Increased by 234.96%

from 51.51M

EPS This Year

-7.67

from 11.64

EPS Next Year

-6.40

from -7.67

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	14.24M	26.82M	36.50M	51.51M	172.54M	384.88M
Revenue Growth	-	-	-	88.36%	36.07%	41.13%	234.96%	123.07%
EPS	-4.74	26.55	-4.23	-6.33	11.64	-7.67	-6.40	-3.43
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	82.2M	220.7M	556.6M
Avg	51.5M	172.5M	384.9M
Low	41.0M	108.8M	228.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	125.3%	328.5%	222.6%
Avg	41.1%	235.0%	123.1%
Low	12.3%	111.2%	32.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-6.72	-5.15	-1.60
Avg	-7.67	-6.40	-3.43
Low	-8.67	-7.20	-8.20

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.